HIVManagement.org

 
Quick Menu / Table of Contents
Introduction Principles Management NRTI Info NNRTI Info
PI Info Fusion Inhibitors Coreceptor Inhibitors Integrase Inhibitors Drug Summary
Investigational Adherence Lab Evaluation Resistance Tests PEP
Antiretroviral Tables OI Prevention Vaccinations TB Therapy Hepatitis Therapy
OI Diagnosis OI Therapy Bibliography Links Palliative Therapy

 

nelfinavir

Detailed Prescribing Information

 

Nelfinavir = Viracept
Dosing Forms Coated 250 mg tablets; 625 mg tablets; oral powder 50 mg/g
Dosing 2 x 625 mg twice a day

or

5 x 250 mg twice a day

or

3 x 250 three times a day,

All nelfinavir regimens should be taken with food, preferably a meal
Boosting with ritonavir is not generally recommended.

Hepatic insufficiency: No data
Renal insufficiency: No adjustment needed
Food dependence Nelfinavir should be taken with food at every dose.  Food increases absorption.
Adverse Effects Soft stools or diarrhea (50%), hepatitis, hyperlipidemia, diabetes, fat redistribution

Diarrhea: consider Imodium, calcium supplement (Tums, Rolaids, Ca carbonate 500 twice a day) or psyllium fiber twice a day

Interactions Efavirenz decreases nelfinavir levels (increase nelfinavir to 6x250 twice a day)

Nevirapine decreases nelfinavir levels (increase nelfinavir to 6x250 twice a day)
Levels of all erectile dysfunction drugs are increased: the lowest dose of these drugs must be used as a maximum and at intervals not be be decreased beyond every 48-72 hours.

Effects of nelfinavir on other drug levels:
Mild increase in indinavir AUC
200-400% increase in saquinavir AUC and Cmax
Significant increase in rifabutin levels: decrease rifabutin to 150 mg daily
100% increase in single dose azithromycin AUC and Cmax
100% increase in atorvastatin AUC and Cmax
500% increase in simvastatin AUC
20-50% reductions in levels of OCPs, methadone, phenytoin
Drugs that increase nelfinavir levels:
Indinavir: 83% increase in AUC and 31% increase in Cmax
Ritonavir 500 mg q12hours: 152% increase in AUC, 44% increase in Cmax
Saquinavir: slight increase
Efavirenz: slight increase
Delavirdine: approx 100% increase in AUC, Cmax, Cmin
Ketoconazole: 15-35% increase
Drugs that decrease nelfinavir levels:
Nevirapine: 32% decrease in Cmin
Rifabutin 150 mg daily: approx 20% decrease
Rifabutin 300 mg daily: approx 25-50% decrease
Carbamazepine
Rifampin 600 mg daily: 75-92% decrease
St John's wort
No data: atazanavir, fosamprenavir, amprenavir
Contraindications Antiarrhythmics: amiodarone, quinidine
Ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine
Neuroleptics: pimozide
Sedatives/hypnotics: midazolam, triazolam

Statins other than atorvastatin, pravastatin
St John's wort

Suggested laboratory evaluations Liver profile and glucose monthly x 3 months, then every 3-4 months; lipid profile q3-4 months
Warnings Carbamazepine decreases nelfinavir levels
Monitor levels of cyclosporine, tacrolimus, sirolimus, phenytoin
Additional contraception should be employed in addition to oral contraceptives
Use reduced doses of drugs for erectile dysfunction
Full Prescribing Information http://www.viracept.com

 

 

Links to Antiretroviral Sections (click on anything)
Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI)
AZT  |  ddC  |  ddI  |  d4T  |  3TC  |  ABC  |  FTC  |  TDF  |  Combivir  |  Trizivir  |  Epzicom  |  Truvada  |  Atripla
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTI)
efavirenz  |  nevirapine  |  delavirdine  |  etravirine
Protease Inhibitors (PI)  Boosted Protease Inhibitors
saquinavir  indinavir  |  ritonavir  |  nelfinavir  |  amprenavir  |  lopinavir + ritonavir  |  atazanavir  |  fosamprenavir  | tipranavir
Fusion Inhibitors
enfuvirtide
Co-Receptor Inhibitors
maraviroc
Integrase inhibitors
raltegravir
 

 

Quick Menu / Table of Contents
Introduction Principles Management NRTI Info NNRTI Info
PI Info Fusion Inhibitors Coreceptor Inhibitors Integrase Inhibitors Drug Summary
Investigational Adherence Lab Evaluation Resistance Tests PEP
Antiretroviral Tables OI Prevention Vaccinations TB Therapy Hepatitis Therapy
OI Diagnosis OI Therapy Bibliography Links Palliative Therapy


Updated 10.17.2007